DIA 2013 49th Annual Meeting
Click here to go to the previous page
Advancing Alzheimer's Innovation: A Call to Action
Track : Track 08:Regulatory Affairs and Submissions
Program Code: 336
Date: Wednesday, June 26, 2013
Time: 10:15 AM to 11:45 AM  EST
Location: 210ABC
CHAIR :
Meryl Comer, (SCHSUP), President, Geoffrey Beene Foundation Alzheimer's Initiative, United States
SPEAKER (S):
George Vradenburg, (SPKSUP), Co-Founder/President, USAgainstAlzheimer's, United States
Rudolph E. Tanzi, PhD (SPKSUP), Head, Genetics and Aging Research Unit; Prof, Neurology, Harvard Medical School, Massachusetts General Hospital, United States
Nicholas A. Kozauer, MD (SPKAGY), Medical Officer, Office of New Drugs, CDER, FDA, United States
 Peter Neumann, DrSc (SPKSUP), Prof of Medicine; Director, Center for Evaluation of Value and Risk in Health, Tufts Medical Center, United States
 Reisa A. Sperling, MD (SPKSUP), Director; Professor, Neurology, Harvard Medical School, Brigham and Women's Hospital and Massachusetts General Hospital, United States
Description
A visionary perspective on how industry and health authorities are working to help move towards a cure for Alzheimer's disease will be provided by a distinguished panel of experts in this inaugural forum. According to the World Alzheimer's Report, currently 36 million have dementia worldwide, and the numbers will increase to 66 million people living with dementia by 2030 and 115 million by 2050. This forum will provide a comprehensive picture of the global impact of this disease and the progress towards earlier detection and meaningful therapeutic intervention. It will also look at key strategies that governments, advocacy groups, and industry are taking to elevate Alzheimer's disease on the global agenda to ensure that society is prepared to address the growing epidemic. This opening forum serves as the foundation for more focused sessions on the patient and caregiver perspectives, and on how to advance clinical development.